Table 5.
Adjuvant regimens administered
Total (n=43) |
|
N (%) | |
Adjuvant treatment regimens | |
Paclitaxel | 12 (27.9) |
Doxorubicin+ifosfamide | 6 (14.0) |
Gemcitabine+docetaxel | 6 (14.0) |
Gemcitabine+docetaxel+doxorubicin+ifosfamide | 5 (11.6) |
Doxorubicin | 3 (7.0) |
Gemcitabine | 2 (4.7) |
Cisplatin | 2 (4.6) |
Docetaxel | 1 (2.3) |
Ifosfamide | 1 (2.3) |
Caelyx | 1 (2.3) |
Epirubicine | 1 (2.3) |
Temozolomide | 1 (2.3) |
Vincristine+dacarbazine | 1 (2.3) |
Vinorelbine | 1 (2.3) |